MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Marketable securities$95,968K Cash and cashequivalents$87,663K Prepaid expenses andother current assets$3,183K Restricted cash$1,250K Total current assets$188,064K Operating leaseright-of-use assets$30,388K Restricted cash$2,000K Property and equipment,net$1,712K Other assets$3K Total assets$222,167K Accumulated deficit-$652,342K Accumulated othercomprehensive gain (loss)-$133K Total liabilities andstockholders deficit$222,167K Total stockholdersdeficit-$76,408K Additional paid-in capital$576,061K Common stock, 0.0001par value...$6K Total liabilities$298,575K Deferred revenue, net ofcurrent portion$193,587K Total currentliabilities$64,404K Operating leaseliabilities, net of current...$40,131K Other liabilities$453K Deferred revenue$52,300K Accrued expenses andother current...$6,924K Accounts payable$3,317K Operating leaseliabilities$1,863K
Balance Sheet

Foghorn Therapeutics Inc. (FHTX)

Foghorn Therapeutics Inc. (FHTX)

source: myfinsight.com